A poorly understood collagen post-translational modification has been 3-prolyl-hydroxylation(P3H) converting proline to 3-hydroxy proline (3-Hyp). It occurs uniquely in the fibrillar collagens,i.e., types I, II and III collagen, at only one proline position, but abundantly in other collagens suchas network collagens, i.e., type IV collagen, where it occurs in up to 10% of residues. This begs thequestion of whether 3-Hyp residues may serve divergent biological functions in different settingsand tissues. In recent data, we have identified a novel protein, CRTAP or Cartilage AssociatedProtein, that is representative of the Leprecanfamily of proteins recently reported to contain aconserved 2-oxoglutarate dioxygenase domain that is found in collagen 4-prolyl-hydroxylases,Hypoxic Inducible Factor (HIF) 4-prolyl-hydoxylases (PDHs), and lysyl hydroxylases (PLODs).Moreover, Leprecan or P3H1 has collagen 3-prolyl-hydroxylase activity in vitro implicating thisfamily of genes as the long sought after PSH's. By combining human and mouse genetic, andproteomic approaches, we show (see Preliminary Studies C.2.) that loss of Crtap in mice causes anosteochondrodysplasia characterized by short stature, kyphosis, and severe osteoporosis.Moreover, this phenotype is biochemically associated with conversion of the single 3-hydroxy-proline to proline in the triple helical domain of types I and II collagen. CRTAP can bind P3H1 andis required for P3H activity in vivo. Finally, we found that loss of CRTAP is associatedwithrecessive osteogenesis imperfecta types VII and ll/lll in humans. These data raise importantquestions that we will address in our Specific Aims. 1) Are the phenotypic features of Crtap loss of function due solely to loss of 3-prolyl-hydroxylation of fibrillar collagens and are there redundant functions with P3H1? 2) Whatare the consequences of 3-Hyp loss in cartilage and bone on cellular differentiation andfunction, and collagen biosynthesis? 3)What is the full human clinical spectrum associatedwith loss of 3-prolyl-hydroxylation of fibrillar collagens? By combining mouse and humanstudies, this proposal will interact directly with Projects I, II, and the Protein Biochemistry Core toanswer these questions.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Program Projects (P01)
Project #
2P01HD022657-21A1
Application #
7245971
Study Section
Pediatrics Subcommittee (CHHD)
Project Start
2007-04-01
Project End
2012-03-31
Budget Start
2007-04-01
Budget End
2008-04-30
Support Year
21
Fiscal Year
2007
Total Cost
$298,796
Indirect Cost
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Joeng, Kyu Sang; Lee, Yi-Chien; Lim, Joohyun et al. (2017) Osteocyte-specific WNT1 regulates osteoblast function during bone homeostasis. J Clin Invest 127:2678-2688
Madan, Simran; Liu, Wei; Lu, James T et al. (2017) A non-mosaic PORCN mutation in a male with severe congenital anomalies overlapping focal dermal hypoplasia. Mol Genet Metab Rep 12:57-61
Rajagopal, Abbhirami; Homan, Erica P; Joeng, Kyu Sang et al. (2016) Restoration of the serum level of SERPINF1 does not correct the bone phenotype in Serpinf1 null mice. Mol Genet Metab 117:378-82
Xue, Yuan; Schoser, Benedikt; Rao, Aliz R et al. (2016) Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death. Circ Cardiovasc Genet 9:130-5
Lietman, Caressa D; Marom, Ronit; Munivez, Elda et al. (2015) A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation. J Bone Miner Res 30:489-98
Hudson, David M; Joeng, Kyu Sang; Werther, Rachel et al. (2015) Post-translationally abnormal collagens of prolyl 3-hydroxylase-2 null mice offer a pathobiological mechanism for the high myopia linked to human LEPREL1 mutations. J Biol Chem 290:8613-22
Chen, Shan; Grover, Monica; Sibai, Tarek et al. (2015) Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton. Mol Genet Metab 115:53-60
Ezgu, F; Krejci, P; Li, S et al. (2014) Phenotype-genotype correlations in patients with Marinesco-Sjögren syndrome. Clin Genet 86:74-84
Grafe, Ingo; Yang, Tao; Alexander, Stefanie et al. (2014) Excessive transforming growth factor-? signaling is a common mechanism in osteogenesis imperfecta. Nat Med 20:670-5
Homan, Erica P; Lietman, Caressa; Grafe, Ingo et al. (2014) Differential effects of collagen prolyl 3-hydroxylation on skeletal tissues. PLoS Genet 10:e1004121

Showing the most recent 10 out of 365 publications